PharmaCyte Biotech Inc (PMCB)
2.10
+0.01
(+0.48%)
USD |
NASDAQ |
May 17, 16:00
2.12
+0.02
(+0.95%)
After-Hours: 20:00
PharmaCyte Biotech Total Liabilities (Quarterly): 22.47M for Jan. 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| January 31, 2024 | 22.47M |
| October 31, 2023 | 20.81M |
| July 31, 2023 | 20.40M |
| April 30, 2023 | 0.5866M |
| January 31, 2023 | 0.8278M |
| October 31, 2022 | 1.311M |
| July 31, 2022 | 1.089M |
| April 30, 2022 | 0.7044M |
| January 31, 2022 | 0.613M |
| October 31, 2021 | 0.1861M |
| July 31, 2021 | 0.925M |
| April 30, 2021 | 0.7248M |
| January 31, 2021 | 0.6487M |
| October 31, 2020 | 0.6647M |
| July 31, 2020 | 1.187M |
| April 30, 2020 | 1.078M |
| January 31, 2020 | 1.019M |
| October 31, 2019 | 0.8039M |
| July 31, 2019 | 0.6066M |
| April 30, 2019 | 0.7429M |
| January 31, 2019 | 0.4712M |
| October 31, 2018 | 0.6624M |
| July 31, 2018 | 0.8829M |
| April 30, 2018 | 0.6442M |
| January 31, 2018 | 0.8872M |
| Date | Value |
|---|---|
| October 31, 2017 | 0.567M |
| July 31, 2017 | 0.8657M |
| April 30, 2017 | 0.5802M |
| January 31, 2017 | 0.5783M |
| October 31, 2016 | 0.449M |
| July 31, 2016 | 0.4565M |
| April 30, 2016 | 0.6376M |
| January 31, 2016 | 1.065M |
| October 31, 2015 | 1.08M |
| July 31, 2015 | 1.186M |
| April 30, 2015 | 1.520M |
| January 31, 2015 | 0.3785M |
| October 31, 2014 | 0.2769M |
| July 31, 2014 | 0.3714M |
| April 30, 2014 | 0.3737M |
| January 31, 2014 | 0.4793M |
| October 31, 2013 | 0.991M |
| July 31, 2013 | 0.9942M |
| April 30, 2013 | 3.798M |
| January 31, 2013 | 3.900M |
| October 31, 2012 | 4.370M |
| July 31, 2012 | 4.607M |
| April 30, 2012 | 3.787M |
| January 31, 2012 | 4.111M |
| October 31, 2011 | 4.101M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
0.1861M
Minimum
Oct 2021
22.47M
Maximum
Jan 2024
4.034M
Average
0.8278M
Median
Jan 2023
Total Liabilities (Quarterly) Benchmarks
| CEL-SCI Corp | 15.74M |
| AIM ImmunoTech Inc | 9.147M |
| IGC Pharma Inc | 2.206M |
| NovaBay Pharmaceuticals Inc | 5.197M |
| Protalix BioTherapeutics Inc | 60.04M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 71.36M |
| Shareholders Equity (Quarterly) | 48.89M |